Insider Trading Alert - CBK, CBG And HUN Traded By Insiders

Yesterday, Dec. 17, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $600.00 to $296,713,529.26.

Highlighted Stocks Traded by Insiders:

Christopher & Banks (CBK) - FREE Research Report

Holman Edwin J, who is Director at Christopher & Banks, bought 25,000 shares at $1.19 on Dec. 17, 2015. Following this transaction, the Director owned 59,015 shares meaning that the stake was boosted by 73.5% with the 25,000-share transaction.

Jones Anne L, who is Director at Christopher & Banks, bought 10,000 shares at $1.19 on Dec. 17, 2015. Following this transaction, the Director owned 119,712 shares meaning that the stake was boosted by 9.11% with the 10,000-share transaction.

Stemper Cindy J, who is SVP, Human Resources at Christopher & Banks, bought 6,000 shares at $1.10 on Dec. 17, 2015. Following this transaction, the SVP, Human Resources owned 26,565 shares meaning that the stake was boosted by 29.18% with the 6,000-share transaction.

The shares most recently traded at $1.21, up $0.11, or 9.09% since the insider transaction. Historical insider transactions for Christopher & Banks go as follows:

  • 4-Week # shares bought: 145,000
  • 4-Week # shares sold: 20,500
  • 12-Week # shares bought: 145,000
  • 12-Week # shares sold: 20,500
  • 24-Week # shares bought: 145,000
  • 24-Week # shares sold: 20,500

The average volume for Christopher & Banks has been 639,100 shares per day over the past 30 days. Christopher & Banks has a market cap of $41.0 million and is part of the services sector and retail industry. Shares are down 78.98% year-to-date as of the close of trading on Thursday.

Christopher & Banks Corporation, through its subsidiaries, operates as a retailer of women's apparel and accessories in the United States. The company designs, sources, and sells women's apparel and accessories to customers ranging in age from 45 to 60. The company has a P/E ratio of 1.4. Currently, there is 1 analyst who rates Christopher & Banks a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBK - FREE

TheStreet Quant Ratings rates Christopher & Banks as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Christopher & Banks Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CBRE Group (CBG) - FREE Research Report

Blum Richard C, who is Director at CBRE Group, sold 36,888 shares at $35.56 on Dec. 17, 2015. Following this transaction, the Director owned 26,189 shares meaning that the stake was reduced by 58.48% with the 36,888-share transaction.

The shares most recently traded at $34.85, down $0.71, or 2.04% since the insider transaction. Historical insider transactions for CBRE Group go as follows:

  • 4-Week # shares sold: 90,000
  • 12-Week # shares sold: 153,000
  • 24-Week # shares sold: 228,540

The average volume for CBRE Group has been 2.2 million shares per day over the past 30 days. CBRE Group has a market cap of $12.1 billion and is part of the financial sector and real estate industry. Shares are up 3.3% year-to-date as of the close of trading on Thursday.

CBRE Group, Inc. operates as a commercial real estate services and investment company worldwide. The company operates through Americas; Europe, Middle East and Africa; Asia Pacific; Global Investment Management; and Development Services segments. The company has a P/E ratio of 21.3. Currently, there are 5 analysts who rate CBRE Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBG - FREE

TheStreet Quant Ratings rates CBRE Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full CBRE Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Huntsman (HUN) - FREE Research Report

Ridd Brian V, who is Sr. VP, Purchasing at Huntsman, bought 3,000 shares at $10.20 on Dec. 17, 2015. Following this transaction, the Sr. VP, Purchasing owned 211,682 shares meaning that the stake was boosted by 1.44% with the 3,000-share transaction.

The shares most recently traded at $10.56, up $0.36, or 3.41% since the insider transaction. Historical insider transactions for Huntsman go as follows:

  • 4-Week # shares bought: 6,067
  • 4-Week # shares sold: 26,974
  • 12-Week # shares bought: 6,067
  • 12-Week # shares sold: 26,974
  • 24-Week # shares bought: 7,067
  • 24-Week # shares sold: 26,974

The average volume for Huntsman has been 5.2 million shares per day over the past 30 days. Huntsman has a market cap of $2.5 billion and is part of the basic materials sector and chemicals industry. Shares are down 56.8% year-to-date as of the close of trading on Thursday.

Huntsman Corporation, together with its subsidiaries, manufactures and sells differentiated organic and inorganic chemical products worldwide. The company operates in five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives. The stock currently has a dividend yield of 4.84%. The company has a P/E ratio of 46.9. Currently, there are 5 analysts who rate Huntsman a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HUN - FREE

TheStreet Quant Ratings rates Huntsman as a hold. The company's strongest point has been its expanding profit margins. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Huntsman Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Oil Falls Sharply After Saudi Arabia, Russia Suggest Production Cut Easing

Oil Falls Sharply After Saudi Arabia, Russia Suggest Production Cut Easing

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

Netflix Ready to Surpass Disney as America's Most Valuable Media Company

Netflix Ready to Surpass Disney as America's Most Valuable Media Company